Translation of remote ischaemic preconditioning into clinical practice.
Reduction of the burden of ischaemia-reperfusion injury is the aim of most treatments for cardiovascular and cerebrovascular disease. Although many strategies have proven benefit in the experimental arena, few have translated to clinical practice. Scientific and practical reasons might explain this...
Principais autores: | Kharbanda, R, Nielsen, T, Redington, A |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2009
|
Registros relacionados
-
BETA-CATENIN PATHWAY EXPRESSION IN HUMAN MYOCARDIUM IS INCREASED BY A REMOTE ISCHAEMIC PRECONDITIONING STIMULUS
por: Contractor, H, et al.
Publicado em: (2009) -
Increased Beta-Catenin Pathway Expression by a Remote Ischaemic Preconditioning Stimulus: First Evidence in Humans
por: Contractor, H, et al.
Publicado em: (2009) -
ADENOSINE RECEPTOR INHIBITION ABOLISHES REMOTE ISCHAEMIC PRECONDITIONING IN HUMANS
por: Contractor, H, et al.
Publicado em: (2009) -
Remote ischaemic preconditioning protects against cardiopulmonary bypass-induced tissue injury: a preclinical study.
por: Kharbanda, R, et al.
Publicado em: (2006) -
Remote ischaemic preconditioning (rIPC) reduces cardiac and pulmonary dysfunction following experimental cardiopulmonary bypass
por: Kharbanda, R, et al.
Publicado em: (2004)